|
Q9950 |
 |
Injection, sulfur hexafluoride lipid microspheres, per ml
| short | Inj sulf hexa lipid microsph |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 5.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 5.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9951 |
|
Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
| short | Locm >= 400 mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued | | OPH | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued |
|
|
|
|
Q9953 |
|
Injection, iron-based magnetic resonance contrast agent, per ml
| short | Inj fe-based mr contrast,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 10.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 10.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9954 |
|
Oral magnetic resonance contrast agent, per 100 ml
| short | Oral mr contrast, 100 ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 18.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 18.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9955 |
|
Injection, perflexane lipid microspheres, per ml
| short | Inj perflexane lip micros,ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued | | OPH | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued |
|
|
|
|
Q9956 |
|
Injection, octafluoropropane microspheres, per ml
| short | Inj octafluoropropane mic,ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 9.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 9.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9957 |
|
Injection, perflutren lipid microspheres, per ml
| short | Inj perflutren lip micros,ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 3.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 3.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9958 |
|
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
| short | Hocm <=149 mg/ml iodine, 1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 300.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 600.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
|
Q9959 |
|
High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
| short | Hocm 150-199mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued | | OPH | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued |
|
|
|
|
Q9960 |
|
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
| short | Hocm 200-249mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 250.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 250.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9961 |
|
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
| short | Hocm 250-299mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 200.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 200.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9962 |
|
High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
| short | Hocm 300-349mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 150.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 200.0 | 3 Date of Service Edit: Clinical | Clinical: Data |
|
|
|
|
Q9963 |
|
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
| short | Hocm 350-399mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 240.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 240.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9964 |
|
High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
| short | Hocm>= 400mg/ml iodine, 1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued | | OPH | 0.0 | 3 Date of Service Edit: Clinical | Drug discontinued |
|
|
|
|
Q9965 |
|
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
| short | Locm 100-199mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
|
|
|
Q9966 |
|
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
| short | Locm 200-299mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 250.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 250.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9967 |
|
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
| short | Locm 300-399mg/ml iodine,1ml |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 300.0 | 3 Date of Service Edit: Clinical | Prescribing Information | | OPH | 300.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
|
Q9968 |
|
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
| short | Visualization adjunct |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
|
|
|
Q9969 |
|
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
| short | Non-heu tc-99m add-on/dose |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 3.0 | 3 Date of Service Edit: Clinical | Clinical: Society Comment | | OPH | 3.0 | 3 Date of Service Edit: Clinical | Clinical: Society Comment |
|
|
|